x

Cerca un progetto di ricerca

* (*) campo obbligatorio

Altra/e opzione/i di ricerca

47 Risultato/i

Ordinato per

Finanziato da un ente associato a IRDiRC =

Progetti di ricerca

AUSTRIA

WIEN
WIEN

Disease progression and treatment-induced alterations in glioblastoma
Allgemeines Krankenhaus der Stadt Wien
Klinisches Institut für Neurologie

AUSTRIA

WIEN
WIEN

Fibroblast Growth Factor Receptor 4 in Glioblastoma
Medizinische Universität Wien
Institut für Krebsforschung

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy
PHARMAXON

GERMANIA

Berlin
BERLIN

Molecular causes ans target molecules in tumor progression of malignant brain tumors
Charité - Universitätsmedizin Berlin (CCM)
Institut für Neuropathologie

ITALIA

LAZIO
ROMA

Finanziato da un ente associato a IRDiRCTHERAGLIO: Microbolle di imaging multimodale guidato e teranostica per gliomi - IT
Università degli Studi di Roma Tor Vergata
Dipartimento di Scienze e Tecnologie Chimiche

PORTOGALLO

CENTRO
BRAGA

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Finanziato da un ente associato a IRDiRCDARTRIX: DARPin Targeted Magnetic Hyperthermic Therapy for Glioblastoma - UK
UCL Cancer Institute, University College London
Recombinant Antibody Therapeutics Group

SPAGNA

Andalucía
GRANADA

SPAGNA

Cataluña
BARCELONA

Finanziato da un ente associato a IRDiRCIntratumoral heterogeneity in glioblastoma. Therapeutic implications
Vall d'Hebron Instituto de Oncología - Centro Cellex
Grupo de expresión génica y cáncer

SPAGNA

Cataluña
LLEIDA

Finanziato da un ente associato a IRDiRCRegulation of the autophagic flux in Glioblastoma: towards the identification of novel therapeutical strategies
Instituto de Investigación Biomédica de Lleida (IRBLLEIDA)
Señalización por calcio y diferenciación neuronal

AUSTRIA

WIEN
WIEN

7 Tesla MR spectoscopy in diffusely infiltrating gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

GERMANIA

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

SPAGNA

Navarra
PAMPLONA

Finanziato da un ente associato a IRDiRCNew therapeutic strategies for diffuse intrinsic pontine gliomas and pediatric high grade gliomas
CIMA - Centro de Investigación Médica Aplicada
Programa de Tumores sólidos y biomarcadores

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCIdentification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCRole of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCThe ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

GERMANIA

Nordrhein-Westfalen
MÜNSTER

Cellular and molecular mechanisms of glioma invasion
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

PORTOGALLO

SUL
LISBOA

Role of protein kinase WNK2 as a tumour suppressor gene in malignant gliomas
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

REGNO UNITO; GRAN BRETAGNA

Nottinghamshire
NOTTINGHAM

REGNO UNITO; GRAN BRETAGNA

West Midlands
BIRMINGHAM

SVEZIA

Landstinget i Uppsala län
UPPSALA

Molecular mechanisms of the origine of glioma development
Uppsala Universitet
Department of Immunology, Genetics and Pathology

ITALIA

CAMPANIA
NAPOLI

Caratterizzazione citogenetica dei tumori del sistema nervoso centrale
P.S.I. "Elena d'Aosta"
U.O.C. Servizio di Genetica

PORTOGALLO

CENTRO
BRAGA

FRANCIA

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

ITALIA

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

REGNO UNITO; GRAN BRETAGNA

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Progetti di ricerca multicentrici